<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629028</url>
  </required_header>
  <id_info>
    <org_study_id>KA 18/71</org_study_id>
    <nct_id>NCT03629028</nct_id>
  </id_info>
  <brief_title>Single or Double-layer Uterine Closure Techniques</brief_title>
  <official_title>Single or Double-layer Uterine Closure Techniques Following Cesarean: An Ongoing Debate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Safak Baran Yilmaz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are different surgical techniques of uterine closure during cesarean. A growing data
      has suggested that the closure technique has an effect on uterine scar healing. Residual
      myometrium thickness and uterine scar defect (niche) development seems to be related to the
      single or double layer closure of uterus. In that study, investigators will search for the
      effect of single or double layer closure of uterus during cesarean on the uterine scar
      defect.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design and participants This study will be assessed cesarean delivery (CD) patients who
      will admit to the Obstetrics and Gynecology Clinic of the Başkent University Adana Dr. Turgut
      Noyan Research and Application Center between July 2018 and September 2019. Specifically,
      participants will be singleton pregnancy patients between 18-45 years of age who will be in
      gestational weeks 24-41 and had not previously received any uterine operations such as CS or
      myomectomy. Patients with multiple pregnancies and/or chronic inflammatory diseases such as
      systemic lupus erythematosus, rheumatoid arthritis, and insulin-dependent diabetes mellitus
      will be excluded. All patients who meet the inclusion criteria will be randomized into two
      treatment groups (i.e., single- or double-layer closures).

      This study was approved by Başkent University Institutional Review Board and Ethics Committee
      (Project no= KA18-71, Approval Date= 7/27/2018), and supported by Başkent University Research
      Fund. Patients who will agree to participate in the study will be informed about the purpose
      of the study before their operations, and each provided signed written consent.

      Participants will be also assessed for maternal age, gravidity, parity, body mass index,
      smoking status, diabetes mellitus, hypertensive diseases of pregnancy, and medical history.
      Regardless of whether they had contractions before surgery, this study also will be
      determined patient CD indications, levels of cervical dilatation, and how CD will be
      established (i.e., elective or emergent).

      Randomization and masking A table of random numbers is used as a simple randomization method
      for placing participants into the two treatment groups. The Research Randomizer website
      (https://www.randomizer.org/) was used to create this table. Before the intervention, the
      next envelope among a previously prepared, sealed, and the number-ordered stack will be
      opened by a nurse for each procedure.

      Surgery technique Six operators will perform CD operations. Access to the abdomen will be
      achieved via Pfannenstiel incision, while the Kerr incision technique will be applied to the
      uterus for all patients. Patients in the single-layer group will be received uterus closures
      with locking, while patients in the double-layer group will be received uterus closures with
      locking in the first layer, but without locking and using the Lambert style in the second
      layer. The decidua will be deliberately excluded during all suturations. A synthetic
      absorbable suture material (Vicryl 1.0, Ethicon, Somerville, NJ, USA) will be used during all
      uterus closures, with corner stitches that will be applied to all patients. Additional suture
      usages and numbers will be reported only in cases of bleeding. Both uterine closure and whole
      operation times will be recorded by the respective operating room technicians. Finally,
      intravenous prophylactic antibiotics (2 g cefazolin sodium) and uterotonic medications (10 IU
      oxytocin) will be routinely applied during all CD procedures.

      Follow-up Postoperative follow-ups will be completed in March 2020. All participants will be
      called after delivery and will be invited to complete sixth-month evaluations. However,
      participants who will experience post-CD pregnancies or uterine surgeries will be excluded.
      All remaining participants will be examined at six to nine months period after CD for niche
      presence in the scar region, niche measurements, scar shape, distance between niche and the
      external cervical os and residual myometrium thickness (RMT), and adjacent myometrium
      thicknesses (AMT). The distance between the niche and external os should be measured parallel
      to the top of the main niche, from the most distal niche point to external os. These
      examinations will be conducted by two experienced sonographers who will be blinded to
      clinical information regarding the closure technique. Procedures will be specifically
      completed using a 4-10 MHz transducer (E8C-RS micro convex endocavity probe, Voluson S6, GE,
      Milwaukee, US), ultrasonography, and through the saline infusion sonohysterography (SIS)
      method. The cervix will be first cleaned with povidone iodine while the patient will be on
      the gynecological examination table prior to ultrasonography. The SIS process then will be
      progressed toward the inside of the endometrial cavity by passing from the cervical os with
      an intrauterine insemination cannula (intrauterine insemination catheter, Wallace Artificial
      Insemination Catheter, Smiths Medical International Ltd., Ashford, Kent, UK). A sterile
      saline solution will be applied to sufficiently distend the cavity, while ultrasonography
      will be conducted via transvaginal probe. At this time, the presence of a hypoechogenic area
      with a depth of 2mm or deeper in the CD scar region within the endometrial cavity will be
      accepted as a niche. Niche dimensions will be determined via 3-axis measurements for depth,
      length, and width. Niche shape, distance to the external cervical os, RMT, and AMT will be
      evaluated. During these follow-ups, patients will be also asked about their menstruation
      processes and any experiences of cervical pain, menstruation pain, postmenstrual bleeding
      (PMB) in the form of spotting, and other abnormal bleeding patterns. Those who will
      experience bleeding for two days or more in the form of spotting after menstruation will be
      defined as PMB. Participants who will use intrauterine devices after CD and/or those who
      could not tolerate speculum application will be examined via transvaginal ultrasonography (TV
      USG).

      Outcomes Primary outcomes will be considered niche presence and measurements, while secondary
      outcomes will be considered RMT, AMT, healing ratio, postmenstrual spotting, and
      dysmenorrhea.

      Statistical analyses The sample size was calculated based on a study by Di Spiezio Sardo et
      al. (2017) titled Risk of Cesarean Scar Defect Following Single- vs Double-Layer Uterine
      Closure: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Their study
      revealed niche formation rates for single- and double-layer closure types of 25% and 43%,
      respectively. Based on tools available at the Power and Sample Size website
      (http://powerandsamplesize.com/Calculators), the needed sample size was calculated at 141 for
      each treatment group with 90% power and 0.05 alpha error.

      All data were statistically analyzed using the IBM SPSS 21.0 software. Categorical
      measurements will be presented as frequencies and percentages, while continuous measurements
      will be summarized as means and standard deviations (median and range when needed).
      Distributions will be checked and the student's t-test was will be used for variables meeting
      the parametric test assumptions when comparing the continuous measurements based on groups,
      while the Mann Whitney U test will be used for those that will not meet the parametric test
      assumptions. Finally, chi-square or Fisher's test statistics will be used to compare
      categorical variables. Statistical significance is set to 0.05 for all tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 18, 2018</start_date>
  <completion_date type="Actual">March 10, 2020</completion_date>
  <primary_completion_date type="Actual">August 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective Randomised Trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Niche Visualized by Saline Infusion Sonography</measure>
    <time_frame>6 to 9 months</time_frame>
    <description>The presence of niche in incision line visualized by saline infusion sonography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Median Depth of Niche</measure>
    <time_frame>6-9 months</time_frame>
    <description>with saline infusion sonohysterography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Median Length of Niche</measure>
    <time_frame>6-9 months</time_frame>
    <description>by saline infusion sonohysterography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Median Width of Niche in Transverse Plane</measure>
    <time_frame>6-9 months</time_frame>
    <description>median width of niche in transverse plane by saline infusion sonohysterograhpy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Residual Myometrium Thickness - 6 to 9 Months</measure>
    <time_frame>6 to 9 months</time_frame>
    <description>The residual myometrium thickness in incision line measured by saline infusion sonography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjacent Myometrium Thickness</measure>
    <time_frame>6 to 9 months</time_frame>
    <description>Adjacent myometrium thickness out of incision line measured by saline infusion sonography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">282</enrollment>
  <condition>Uterine Scar</condition>
  <condition>Cesarean Section Complications</condition>
  <condition>Cesarean Section; Dehiscence</condition>
  <arm_group>
    <arm_group_label>Single Layer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diagnostic Test: Niche Presence in 6 to 9 months Diagnostic Test: Niche Measurements (depth of niche, the length of niche, the width of the niche in the transverse plane) Diagnostic Test: Residual myometrium thickness Diagnostic Test: Adjacent myometrium thickness Symptoms: postmenstrual bleeding/dysmenorrhea</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double Layer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diagnostic Test: Niche Presence in 6 to 9 months Diagnostic Test: Niche Measurements (depth of niche, the length of niche, the width of the niche in the transverse plane) Diagnostic Test: Residual myometrium thickness Diagnostic Test: Adjacent myometrium thickness Symptoms: postmenstrual bleeding/dysmenorrhea</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Residual myometrium thickness</intervention_name>
    <description>The myometrium will be closed by single or double layer during cesarean and residual myometrium thickness will be evaluated in 6 to 9 months by saline infusion sonography.</description>
    <arm_group_label>Double Layer</arm_group_label>
    <arm_group_label>Single Layer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Niche Presence</intervention_name>
    <description>The myometrium will be closed by single or double layer during cesarean and niche presence will be evaluated in 6 to 9 months by saline infusion sonography.</description>
    <arm_group_label>Double Layer</arm_group_label>
    <arm_group_label>Single Layer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Adjacent myometrium thickness</intervention_name>
    <description>The myometrium will be closed by single or double layer during cesarean and adjacent myometrium thickness will be evaluated in 6 to 9 months by saline infusion sonography.</description>
    <arm_group_label>Double Layer</arm_group_label>
    <arm_group_label>Single Layer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Niche Measurements (depth of niche, width of niche, length of niche)</intervention_name>
    <description>The myometrium will be closed by single or double layer during cesarean and three dimensional niche measurements will be evaluated in 6 to 9 months by saline infusion sonography.</description>
    <arm_group_label>Double Layer</arm_group_label>
    <arm_group_label>Single Layer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary cesarean, singleton pregnancy,

        Exclusion Criteria:

          -  Multiple pregnancy, History of any uterine surgery, wound healing diseases (insulin
             dependent diabetes mellitus, rheumatoid arthritis, systemic lupus erythematous,
             inflammatory bowel disease)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only women who underwent cesarean section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Şafak YILMAZ BARAN, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baskent University Department of Obstetrics and Gynecology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baskent University Adana Seyhan Uygulama Hastanesi</name>
      <address>
        <city>Adana</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Di Spiezio Sardo A, Saccone G, McCurdy R, Bujold E, Bifulco G, Berghella V. Risk of Cesarean scar defect following single- vs double-layer uterine closure: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2017 Nov;50(5):578-583. doi: 10.1002/uog.17401. Epub 2017 Oct 9. Review.</citation>
    <PMID>28070914</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <results_first_submitted>March 15, 2020</results_first_submitted>
  <results_first_submitted_qc>April 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 1, 2020</results_first_posted>
  <last_update_submitted>April 18, 2020</last_update_submitted>
  <last_update_submitted_qc>April 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>Safak Baran Yilmaz</investigator_full_name>
    <investigator_title>Specialist Dr. Şafak YILMAZ BARAN M.D.</investigator_title>
  </responsible_party>
  <keyword>cesarean section, niche, isthmocele, uterine closure</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 27, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03629028/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Single Layer</title>
          <description>Age:18-45 Years,Only women who underwent cesarean section Inclusion Criteria:Primary cesarean, singleton pregnancy, Exclusion Criteria:Multiple pregnancy, History of any uterine surgery, wound healing diseases (insulin dependent diabetes mellitus, rheumatoid arthritis, systemic lupus erythematous, inflammatory bowel disease) Uterus will be sutured in locked single layer during cesarean Diagnostic Test: Total myometrium thickness, Residual myometrium thickness, Niche Presence and Measurements in 3D will be evaluated in 6th months by saline infusion sonography.</description>
        </group>
        <group group_id="P2">
          <title>Double Layer</title>
          <description>Age:18-45 Years,Only women who underwent cesarean section Inclusion Criteria:Primary cesarean, singleton pregnancy, Exclusion Criteria:Multiple pregnancy, History of any uterine surgery, wound healing diseases (insulin dependent diabetes mellitus, rheumatoid arthritis, systemic lupus erythematous, inflammatory bowel disease) Uterus will be sutured in double layer during cesareanDiagnostic Test: Total myometrium thickness, Residual myometrium thickness, Niche Presence and Measurements in 3D will be evaluated in 6th months by saline infusion sonography.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="141"/>
                <participants group_id="P2" count="141"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="109"/>
                <participants group_id="P2" count="116"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>intolerance to examination</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>same ethnic origin, 18-45 age, who underwent first cesarean operation</population>
      <group_list>
        <group group_id="B1">
          <title>Single Layer</title>
          <description>uterus will be sutured by single layer</description>
        </group>
        <group group_id="B2">
          <title>Double Layer</title>
          <description>uterus will be sutured by double layer</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="109"/>
            <count group_id="B2" value="116"/>
            <count group_id="B3" value="225"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.8" spread="4.1"/>
                    <measurement group_id="B2" value="30.8" spread="5.1"/>
                    <measurement group_id="B3" value="30.3" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="109"/>
                    <measurement group_id="B2" value="116"/>
                    <measurement group_id="B3" value="225"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="109"/>
                    <measurement group_id="B2" value="116"/>
                    <measurement group_id="B3" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.9" spread="4.2"/>
                    <measurement group_id="B2" value="29.8" spread="4.6"/>
                    <measurement group_id="B3" value="29.3" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age at delivery</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38" spread="2"/>
                    <measurement group_id="B2" value="38.1" spread="2.1"/>
                    <measurement group_id="B3" value="38.1" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>birth weight</title>
          <units>g</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3191.5" spread="570"/>
                    <measurement group_id="B2" value="3261.4" spread="633"/>
                    <measurement group_id="B3" value="3227.3" spread="602.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension in pregnancy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of infertility</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nulliparity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Emergent cesarean section</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Contractions before labor</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>≥4 cm cervical dilatation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Need for additional suture</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of uterine closure</title>
          <units>min</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.5" lower_limit="1" upper_limit="9"/>
                    <measurement group_id="B2" value="6.15" lower_limit="1.5" upper_limit="20"/>
                    <measurement group_id="B3" value="5.2" lower_limit="1" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Operation time</title>
          <units>min</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" lower_limit="15" upper_limit="45"/>
                    <measurement group_id="B2" value="30" lower_limit="20" upper_limit="50"/>
                    <measurement group_id="B3" value="27" lower_limit="15" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of labor</title>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="1" upper_limit="18"/>
                    <measurement group_id="B2" value="1" lower_limit="1" upper_limit="20"/>
                    <measurement group_id="B3" value="1" lower_limit="1" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Niche Visualized by Saline Infusion Sonography</title>
        <description>The presence of niche in incision line visualized by saline infusion sonography</description>
        <time_frame>6 to 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Layer</title>
            <description>niche presence</description>
          </group>
          <group group_id="O2">
            <title>Double Layer</title>
            <description>niche presence</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Niche Visualized by Saline Infusion Sonography</title>
          <description>The presence of niche in incision line visualized by saline infusion sonography</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>number and percentage of niche by saline infusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>the presence of niche by tv ultrasound</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The sample size was calculated based on the study of Sardo et al. The website http://powerandsamplesize.com/Calculators was used. As a result of the sample size calculation with 90% power and 0.05 alpha error, it was planned to include 141 patients in each group.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Data compared to meta-analysis conducted in Sardo et al., 2017</non_inferiority_desc>
            <p_value>0.05</p_value>
            <method>Chi-squared</method>
            <method_desc>Chi-squared or Fisher’s test statistic was used to compare the categorical variables.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Median Depth of Niche</title>
        <description>with saline infusion sonohysterography</description>
        <time_frame>6-9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Layer</title>
            <description>single layer median depth of niche</description>
          </group>
          <group group_id="O2">
            <title>Double Layer</title>
            <description>double layer median depth of niche</description>
          </group>
        </group_list>
        <measure>
          <title>Median Depth of Niche</title>
          <description>with saline infusion sonohysterography</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" lower_limit="0" upper_limit="8.4"/>
                    <measurement group_id="O2" value="2.4" lower_limit="0" upper_limit="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Median Length of Niche</title>
        <description>by saline infusion sonohysterography</description>
        <time_frame>6-9 months</time_frame>
        <population>of the 225 partipicants included the study</population>
        <group_list>
          <group group_id="O1">
            <title>Single Layer</title>
            <description>median length niche</description>
          </group>
          <group group_id="O2">
            <title>Double Layer</title>
            <description>median length niche</description>
          </group>
        </group_list>
        <measure>
          <title>Median Length of Niche</title>
          <description>by saline infusion sonohysterography</description>
          <population>of the 225 partipicants included the study</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="0" upper_limit="6.7"/>
                    <measurement group_id="O2" value="3.8" lower_limit="0" upper_limit="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Median Width of Niche in Transverse Plane</title>
        <description>median width of niche in transverse plane by saline infusion sonohysterograhpy</description>
        <time_frame>6-9 months</time_frame>
        <population>of the 225 participants included the study</population>
        <group_list>
          <group group_id="O1">
            <title>Single Layer</title>
            <description>median niche width in transverse plane</description>
          </group>
          <group group_id="O2">
            <title>Double Layer</title>
            <description>median niche width in transverse plane</description>
          </group>
        </group_list>
        <measure>
          <title>Median Width of Niche in Transverse Plane</title>
          <description>median width of niche in transverse plane by saline infusion sonohysterograhpy</description>
          <population>of the 225 participants included the study</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" lower_limit="0" upper_limit="7.4"/>
                    <measurement group_id="O2" value="4" lower_limit="0" upper_limit="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Residual Myometrium Thickness - 6 to 9 Months</title>
        <description>The residual myometrium thickness in incision line measured by saline infusion sonography</description>
        <time_frame>6 to 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Layer</title>
            <description>Residual myometrium thickness</description>
          </group>
          <group group_id="O2">
            <title>Double Layer</title>
            <description>Residual myometrium thickness</description>
          </group>
        </group_list>
        <measure>
          <title>Residual Myometrium Thickness - 6 to 9 Months</title>
          <description>The residual myometrium thickness in incision line measured by saline infusion sonography</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.6" lower_limit="3.7" upper_limit="21"/>
                    <measurement group_id="O2" value="9.4" lower_limit="3" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adjacent Myometrium Thickness</title>
        <description>Adjacent myometrium thickness out of incision line measured by saline infusion sonography</description>
        <time_frame>6 to 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Layer</title>
            <description>Adjacent myometrium thickness</description>
          </group>
          <group group_id="O2">
            <title>Double Layer</title>
            <description>adjacent myometrium thickness</description>
          </group>
        </group_list>
        <measure>
          <title>Adjacent Myometrium Thickness</title>
          <description>Adjacent myometrium thickness out of incision line measured by saline infusion sonography</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.1" lower_limit="6.8" upper_limit="22.6"/>
                    <measurement group_id="O2" value="12" lower_limit="4.9" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>no serious adverse event occured</desc>
      <group_list>
        <group group_id="E1">
          <title>Single Layer-</title>
          <description>Presence of niche, niche measurements, measurement of residual/ adjacent myometrium thickness</description>
        </group>
        <group group_id="E2">
          <title>Double Layer</title>
          <description>Presence of niche, niche measurements, measurement of residual/ adjacent myometrium thickness</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="109"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="116"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="109"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="116"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1.1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="109"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>pregnancy occurred after cesarean</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="109"/>
                <counts group_id="E2" events="2" subjects_at_risk="116"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Şafak Yılmaz Baran, MD</name_or_title>
      <organization>Principal investigator of the research</organization>
      <phone>+903224586868</phone>
      <email>safakyilmazbaran@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

